Updated information on COVID-19 and Flu: Restricted visitation is now in effect
Category
Cancer
Sub Category
Hematology
Study Name
S1608: Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma
Principal Investigator
Gordan Srkalovic
Study Information
S1608: Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma
Contact for Questions
Clinical Trials Office – 517.364.9400

Site view: at a glance